antifungal therapy – Page 2

Endogenous Endophthalmitis: An underestimated serious complication in patients with disseminated fusariosis

mycolabadmin

An 18-year-old cancer patient undergoing chemotherapy developed a serious infection with Fusarium, a mold that spread throughout his body including to his eyes, causing vision problems. Doctors treated him with a combination of antifungal medications given both systemically and directly injected into his eyes. Although the infection was controlled and his life was saved, he lost most of his vision in both eyes but was able to keep them rather than requiring removal.

A case report of disseminated histoplasmosis not responding to primary treatment by itraconazole

mycolabadmin

A 28-year-old woman developed a fungal infection called histoplasmosis after having a tooth extracted, with the infection spreading to her lungs and sinuses. She was initially given a common antifungal medication called itraconazole, but her condition continued to worsen despite increasing the dose. When doctors switched her to a stronger medication called liposomal amphotericin B given intravenously, she improved dramatically and recovered fully. This case shows the importance of recognizing when a standard fungal treatment is not working and switching to more aggressive therapy.

Fungal Pneumonia and Severe Neutropenia: Risk Factors for Increased 90 Day Mortality

mycolabadmin

This study examined 39 cancer patients with severe fungal lung infections treated at a major cancer center. Patients who received antifungal treatment within 7 days and started with a specific drug called liposomal amphotericin B had better survival rates at 90 days. The research suggests that quick diagnosis and prompt treatment initiation are critical for improving survival in immunocompromised patients with fungal pneumonia.

Humans vs. Fungi: An Overview of Fungal Pathogens against Humans

mycolabadmin

Fungal infections are serious health threats that kill approximately 1.5 million people annually worldwide. This comprehensive review identifies over 280 different fungal species that can infect humans, with Aspergillus being the most dangerous genus. The study provides updated information on how these infections are diagnosed through various methods including cultures, microscopy, and molecular testing, as well as treatment options ranging from traditional antifungal drugs to newer therapies like nanotechnology-based formulations.

A Case of Superficial Mycoses in a Patient with Systemic Lupus Erythematosus

mycolabadmin

A 52-year-old woman with lupus developed a widespread fungal skin infection that was initially mistaken for worsening lupus symptoms. The infection affected her scalp, face, and nails with two different types of fungi. After six months of treatment with antifungal medications, her symptoms resolved completely with no return of the infection during follow-up.

Wildlife Dermatophytoses in Central Italy (Umbria and Marche Regions): A Fifteen-Year Investigation (2010–2024)

mycolabadmin

Researchers studied fungal skin infections in wild animals across two Italian regions over 15 years, finding that about 11% carried dermatophyte fungi. Grey squirrels were most commonly infected, and some of these fungi can spread to humans through contact. The study highlights how wild animals act as sentinels for emerging diseases and emphasizes the importance of protective equipment when handling wildlife.

Peritoneal dialysis-related peritonitis caused by Fusarium: a case report and literature review

mycolabadmin

A 61-year-old farmer on peritoneal dialysis developed a rare fungal infection caused by Fusarium after antibiotics failed to treat her peritonitis. Pharmacists helped doctors switch her to the antifungal medication voriconazole and carefully monitored blood levels to ensure the dose was high enough. After adjusting the dose based on blood tests, the patient recovered completely with no symptoms and normal test results within two months.

A rare case of white piedra caused by Candida orthopsilosis

mycolabadmin

A young girl developed small knots on her scalp hair caused by a yeast fungus called Candida orthopsilosis. This is extremely rare, as white piedra is typically caused by different fungi. Doctors identified the fungus using DNA testing and treated it successfully with antifungal creams and shampoo. This case shows that doctors should not dismiss Candida growth as contamination when found on hair.

Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis

mycolabadmin

Researchers developed a new antifungal gel containing luliconazole loaded into tiny lipid nanoparticles to treat stubborn fungal skin infections caused by Trichophyton indotineae that resist standard terbinafine treatment. Testing in guinea pigs showed this new nanoformulation penetrated skin better and cleared infections faster (21 days) compared to regular luliconazole gel (28 days) and terbinafine-treated animals. The nanoparticle delivery system improved the drug’s ability to reach infected skin layers and showed no harmful side effects, offering promise for treating resistant fungal infections in patients.

Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy

mycolabadmin

This report describes two patients who developed rare fungal eye infections caused by Curvularia geniculata after eye injuries. Both patients were successfully treated with antifungal eye drops, particularly natamycin. Molecular testing confirmed the specific fungus causing the infection. Both patients recovered well with excellent vision restoration, demonstrating that proper diagnosis and targeted antifungal treatment can effectively manage this rare condition.

Research Keyword: antifungal therapy